INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
Provided By PR Newswire
Last update: Jan 9, 2025
PLYMOUTH MEETING, Pa., Jan. 9, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today highlighted anticipated milestones for 2025 and key accomplishments from 2024 in advance of upcoming investor meetings.
Read more at prnewswire.com
